Remission of intestinal Behçet's disease treated with anti-tumor necrosis factor α monoclonal antibody (Infliximab)

Korean Journal of Internal Medicine

Volumn 22, Issue 1, 2007, Pages 24-27

  Lee, Jung Hoon ^a   Kim, Tae Nyeun ^a   Choi, Sun Taek ^a   Jang, Byung Ik ^a   Shin, Kyeong Cheol ^a   Lee, Sam Beom ^a   Shim, Young Ran ^a  

^a Yeungnam University College of Medicine   (South Korea)

Author keywords

Behcet syndrome; Infliximab; Tumor necrosis factor alpha

Indexed keywords

AZATHIOPRINE; INFLIXIMAB; GASTROINTESTINAL AGENT; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; BEHCET DISEASE; BLOOD TOXICITY; CASE REPORT; DRUG WITHDRAWAL; GENITAL ULCER; HEMICOLECTOMY; HUMAN; INTESTINAL BLEEDING; INTESTINE ULCER; MALE; MOUTH ULCER; RECURRENT DISEASE; REMISSION; COLON RESECTION; DISEASE COURSE; GASTROINTESTINAL DISEASE; MIDDLE AGED; PATHOPHYSIOLOGY; TREATMENT OUTCOME;

ANTIBODIES, MONOCLONAL; BEHCET SYNDROME; COLECTOMY; DISEASE PROGRESSION; GASTROINTESTINAL AGENTS; GASTROINTESTINAL DISEASES; HUMANS; MALE; MIDDLE AGED; REMISSION INDUCTION; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34248588786     PISSN: 12263303     EISSN: 20056648     Source Type: Journal    
DOI: 10.3904/kjim.2007.22.1.24     Document Type: Article

References (19)

1. Behet H. Ueber rezidivierende aphtese durch ein virus verusachte Geswuere am Mund, am Auge und an den Genitalien. Dermatol Wochenschr 105:1152-1157, 1937
2. Sakane T, Takeno M, Suzuki N, Inaba G. Behet's disease. N Engl J Med 341:1284-1291, 1999
3. Bayraktar Y, Ozaslan E, van Thiel DH. Gastrointestinal manifestations of Behcet's disease. J Clin Gastroenterol 30:144-154, 2000
4. Travis SP, Czajkowski M, McGovern DP, Watson RG, Bell AL. Treatment of intestinal Behet's syndrome with chimeric tumour necrosis factor alpha antibody. Gut 49:725-728, 2001
5. Kram MT, May LD, Goodman S, Molinas S. Behcet's ileocolitis: successful treatment with tumor necrosis factor-alpha antibody (infliximab) therapy: report of a case. Dis Colon Rectum 46:118-121, 2003
6. Best WR, Becktel JM, Singleton JW. Rederived values of the eight coefficients of the Crohn's Disease Activity Index (CDAI). Gastroenterology 77:843-846, 1979
7. Harvey RF, Bradshaw JM. A simple index of Crohn's disease activity. Lancet 1:514, 1980
8. Masugi J, Matsui T, Fujimori T, Maeda S. A case of Behcet's disease with multiple longitudinal ulcers all over the colon. Am J Gastroenterol 89:778-780, 1994
9. Choi IJ, Kim JS, Cha SD, Jung HC, Park JG, Song IS, Kim CY. Long-term clinical course and prognostic factors in intestinal Behcet's disease. Dis Colon Rectum 43:692-700, 2000
10. Gul A. Behet's disease: an update on the pathogenesis. Clin Exp Rheumatol 19:S6-S12, 2001
11. Suzuki Y, Hoshi K, Matsuda T, Mizushima Y. Increased peripheral blood gamma delta+ T cells and natural killer cells in Behcet's disease. J Rheumatol 19:588-592, 1992
12. Yamashita N, Kaneoka H, Kaneko S, Takeno M, Oneda K, Koizumi H, Kongure M, Inaba G, Sakane T. Role of gammadelta T lymphocytes in the development of Behcet's disease. Clin Exp Immunol 107:241-247, 1997
13. Sfikakis PP. Behcet's disease: a new target for anti-tumour necrosis factor treatment. Ann Rheum Dis 61:ii51-ii53, 2002
14. Cha SD, Lim YS, Kim JW, Kim CG, Kim JS, Chang DK, Jung HC, Song IS, Choi KW, Kim CY. Response to medical therapy, course and recurrence of colonic lesions in behcet's colitis. Korean J Gastroenterol 30:472-480, 1997
15. Kasahara Y, Tanaka S, Nishino M, Umemura H, Shiraha S, Kuyama T. Intestinal involvement in Behcet's disease: review of 136 surgical cases in the Japanease literature. Dis Colon Rectum 24:103-106, 1981
16. International Study Group for Behcet's Disease. Criteria for diagnosis of Behcet's disease. Lancet 335:1078-1080, 1990
17. Robertson LP, Hickling P. Treatment of recalcitrant orogenital ulceration of Behcet's syndrome with Infliximab. Rheumatology 40:473-474, 2001
18. Munoz-Fernandez S, Hidalgo V, Fernandez-Melon J, Schlincker A, Martin-Mola E. Effect of infliximab on threatening panuveitis in Behcet's disease. Lancet 358:1644, 2001
19. Hassard PV, Binder SW, Nelson V, Vasiliauskas EA. Anti-tumor necrosis factor monoclonal antibody therapy for gastrointestinal Behcet's disease: a case report. Gastroenterology 120:995-999, 2001